Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients

Update Il y a 4 ans
Reference: NCT01812434

Woman and Man

Extract

Hypothesis 1: Treatment of heart transplant recipients with sildenafil, a PDE-5 inhibitor, will improve small artery elasticity (SAE) when compared to placebo. Hypothesis 2: PDE-5 inhibition will improve endothelial function, resulting in increased production of nitric oxide, reduced activation of circulating endothelial cells, and increased endothelial progenitor cells.


Inclusion criteria

  • Cardiac Allograft Vasculopathy

Links